Details of the Drug

General Information of Drug (ID: DMU4K5P)

Drug Name
PD-L1 mAb + LY
Indication
Disease Entry ICD 11 Status REF
Solid tumour/cancer 2A00-2F9Z Phase 1 [1]
Cross-matching ID
TTD ID
D0IW6R

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)